MedTrace Logo

Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD

NCT05897606 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2023-06-09

No results posted yet for this study

Summary

The study was performed on 160 participants, to ensure the impact of multi vitamin and mineral to reduce NAFLD

Conditions

  • Non-Alcoholic Fatty Liver Disease

Interventions

COMBINATION_PRODUCT

Multiviamins and minerals

The intervention group received one capsule of multivitamin and minerals supplements every day, one hour after breakfast, for 12 weeks.

COMBINATION_PRODUCT

Placebo

Placebo

Sponsors & Collaborators

  • Sulaimany Polytechnic university

    lead OTHER

Principal Investigators

  • HAWAL F Lateef, Msc · Nursing Department, Kalar Technical College, Sulaimani polytechnic university, Sulaimani, Iraq

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
78 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2023-05-02
Completion
2023-05-03
FDA Drug
Yes
FDA Device
Yes

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05897606 on ClinicalTrials.gov